Norges Bank’s Pfizer PFE Stock Holding History

Norges Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-73,533,577	Closed	-$1.83B	–	1009
2025 Q4	$1.83B	Buy	+73,533,577	New	+$1.85B	0.2%	93
2025 Q3	–	Sell	-93,653,338	Closed	-$2.27B	–	1128
2025 Q2	$2.27B	Buy	93,653,338 +7,599,536	+9%	+$177M	0.28%	58
2025 Q1	$2.18B	Sell	86,053,802 -1,733,080	-2%	-$45.4M	0.31%	55
2024 Q4	$2.33B	Sell	87,786,882 -567,529	-0.6%	-$15.4M	0.31%	54
2024 Q3	$2.56B	Buy	88,354,411 +4,391,223	+5%	+$128M	0.36%	44
2024 Q2	$2.35B	Buy	83,963,188 +7,244,630	+9%	+$199M	0.35%	47
2024 Q1	$2.13B	Buy	76,718,558 +2,737,078	+4%	+$75.9M	0.34%	52
2023 Q4	$2.13B	Buy	73,981,480 +5,435,892	+8%	+$164M	0.37%	48
2023 Q3	$2.27B	Buy	68,545,588 +1,854,101	+3%	+$65.6M	0.46%	36
2023 Q2	$2.45B	Buy	66,691,487 +2,029,519	+3%	+$79M	0.48%	35
2023 Q1	$2.64B	Buy	64,661,968 +3,177,346	+5%	+$137M	0.58%	29
2022 Q4	$3.15B	Buy	61,484,622 +3,660,481	+6%	+$175M	0.76%	17
2022 Q3	$2.53B	Buy	57,824,141 +1,271,300	+2%	+$61.8M	0.67%	21
2022 Q2	$2.97B	Buy	56,552,841 +2,056	+0%	+$105K	0.77%	15
2022 Q1	$2.93B	Sell	56,550,785 -212,819	-0.4%	-$11M	0.64%	23
2021 Q4	$3.35B	Buy	56,763,604 +200,794	+0.4%	+$9.95M	0.69%	14
2021 Q3	$2.43B	Sell	56,562,810 -2,324,995	-4%	-$103M	0.54%	27
2021 Q2	$2.31B	Sell	58,887,805 -2,741,536	-4%	-$107M	0.5%	29
2021 Q1	$2.23B	Buy	61,629,341 +1,332,349	+2%	+$47.3M	0.51%	26
2020 Q4	$2.22B	Sell	60,296,992 -1,029,605	-2%	-$37.8M	0.52%	31
2020 Q3	$2.14B	Sell	61,326,597 -489,956	-0.8%	-$17.2M	0.57%	29
2020 Q2	$1.92B	Sell	61,816,553 -762,353	-1%	-$25.9M	0.55%	30
2020 Q1	$1.94B	Hold	62,578,906	–	–	0.69%	21
2019 Q4	$2.33B	Sell	62,578,906 -322,308	-0.5%	-$11.5M	0.65%	24
2019 Q3	$2.14B	Buy	62,901,214 +388,829	+0.6%	+$14.1M	0.66%	25
2019 Q2	$2.57B	Sell	62,512,385 -1,019,734	-2%	-$40.5M	0.79%	17
2019 Q1	$2.56B	Buy	63,532,119 +2,452,641	+4%	+$98.2M	0.83%	18
2018 Q4	$2.53B	Buy	61,079,478 +1,040,946	+2%	+$43.2M	0.94%	12
2018 Q3	$2.51B	Buy	60,038,532 +53,262	+0.1%	+$2.05M	0.82%	12
2018 Q2	$2.06B	Sell	59,985,270 -976,088	-2%	-$33.4M	0.71%	20
2018 Q1	$2.05B	Buy	60,961,358 +290,117	+0.5%	+$9.97M	0.74%	16
2017 Q4	$2.08B	Sell	60,671,241 -438,872	-0.7%	-$15M	0.75%	20
2017 Q3	$2.07B	Sell	61,110,113 -115,193	-0.2%	-$3.7M	0.79%	17
2017 Q2	$1.95B	Sell	61,225,306 -2,177,824	-3%	-$68.7M	0.77%	19
2017 Q1	$2.06B	Buy	63,403,130 +1,847,640	+3%	+$58.3M	0.84%	16
2016 Q4	$1.9B	Buy	61,555,490 +1,819,760	+3%	+$55.6M	0.83%	19
2016 Q3	$1.83B	Buy	59,735,730 +456,276	+0.8%	+$15.3M	0.87%	15
2016 Q2	$1.98B	Sell	59,279,454 -315,465	-0.5%	-$10.1M	0.94%	15
2016 Q1	$1.68B	Buy	59,594,919 +99,829	+0.2%	+$2.85M	0.82%	18
2015 Q4	$1.82B	Buy	59,495,090 +4,081,346	+7%	+$128M	0.91%	14
2015 Q3	$1.65B	Buy	55,413,744 +2,616,672	+5%	+$83.9M	0.87%	12
2015 Q2	$1.68B	Buy	52,797,072 +1,067,684	+2%	+$34.8M	0.84%	15
2015 Q1	$1.71B	Sell	51,729,388 -5,575,144	-10%	-$177M	0.84%	15
2014 Q4	$1.69B	Buy	57,304,532 +1,242,267	+2%	+$35.6M	0.86%	16
2014 Q3	$1.57B	Sell	56,062,265 -54,479,027	-49%	-$1.53B	0.85%	15
2014 Q2	$3.11B	Buy	110,541,292 +56,805,789	+106%	+$1.62B	0.84%	15
2014 Q1	$1.64B	Sell	53,735,503 -1,777,525	-3%	-$53M	0.92%	14
2013 Q4	$1.61B	Sell	55,513,028 -4,334,176	-7%	-$126M	0.93%	12
2013 Q3	$1.63B	Buy	59,847,204 +8,239,597	+16%	+$224M	0.95%	14
2013 Q2	$1.37B	Buy	+51,607,607	New	+$1.43B	0.85%	16

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Norges Bank's PFE Position: Q1 2026 in Review

Norges Bank sold out of Pfizer (PFE) in Q1 2026, closing a stake of 73,533,577 shares — an estimated $1.83B sold.

Norges Bank first reported a position in PFE in Q2 2013 and held it in 50 quarters. The position peaked at $3.35B in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Norges Bank reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 73,533,577 Pfizer shares in Q1 2026, an estimated $1.83B.
Norges Bank first reported a position in Pfizer in Q2 2013 and held it in 50 quarters.
Norges Bank's Pfizer position peaked at $3.35B in Q4 2021.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.